News tagged with medtronic
Landmark editorial denounces 'poor publication practices' in spine research
Loyola University Hospital spine surgeon Dr. Alexander Ghanayem is co-author of a landmark editorial challenging the integrity of published industry-sponsored research involving a bone-growth product.
Other
Jun 28, 2011 |
5 / 5 (2) |
0
Study finds increased cancer risk with bone growth product
Spine surgery patients who got a bone growth stimulating agent as part of a clinical trial were three to five times more likely to develop cancer two to three years after being implanted with the product, according to a new ...
Cancer
Nov 04, 2011 |
5 / 5 (1) |
0
Bolus epidural fentanyl cuts post-spinal decompression pain
(HealthDay)—Intraoperative bolus epidural fentanyl is effective at alleviating early postoperative pain after lumbar canal decompression, according to a study published online Aug. 27 in The Spine Journal.
Surgery
Sep 07, 2012 |
5 / 5 (1) |
0
Increased serum metal levels after lumbar disc replacement
(HealthDay)—Serum metal levels of cobalt and chromium are elevated at all postoperative time points up to 36 months following metal-on-metal lumbar disc replacement, according to research published in the ...
Other
Dec 22, 2012 |
4 / 5 (1) |
0
Medtronic
Medtronic, Inc. (NYSE: MDT), based in suburban Minneapolis, Minnesota, is the world's largest[citation needed] medical technology company and is a Fortune 500 company.
For more information about Medtronic, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
